Research Output per year
Fingerprint Dive into the research topics where Loredana Amoroso is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Neuroblastoma
Medicine & Life Sciences
Pediatrics
Medicine & Life Sciences
Bone Marrow
Medicine & Life Sciences
Topotecan
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
temozolomide
Medicine & Life Sciences
HLA-G Antigens
Medicine & Life Sciences
Brachiocephalic Veins
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2004 2018
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer
Moreno, L., Casanova, M., Chisholm, J. C., Berlanga, P., Chastagner, P. B., Baruchel, S., Amoroso, L., Gallego Melcón, S., Gerber, N. U., Bisogno, G., Fagioli, F., Geoerger, B., Glade Bender, J. L., Aerts, I., Bergeron, C., Hingorani, P., Elias, I., Simcock, M., Ferrara, S., Le Bruchec, Y. & 3 others, , Sep 2018, In : European Journal of Cancer. 100, p. 27-34 8 p.Research output: Contribution to journal › Article
Investigational Therapies
Pediatrics
Ewing's Sarcoma
Neoplasms
Neutropenia
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer
Moreno, L., Casanova, M., Chisholm, J. C., Berlanga, P., Chastagner, P. B., Baruchel, S., Amoroso, L., Melcón, S. G., Gerber, N. U., Bisogno, G., Fagioli, F., Geoerger, B., Glade Bender, J. L., Aerts, I., Bergeron, C., Hingorani, P., Elias, I., Simcock, M., Ferrara, S., Le Bruchec, Y. & 3 others, , 2018, In : European journal of cancer. 100, p. 27-34 8 p.Research output: Contribution to journal › Article
6
Citations
(Scopus)
Topotecan-vincristine-doxorubicin in stage 4 high-risk neuroblastoma patients failing to achieve a complete metastatic response to rapid COJEC: A SIOPEN study
Amoroso, L., Erminio, G., Makin, G., Pearson, A. D. J., Brock, P., Valteau-Couanet, D., Castel, V., Pasquet, M., Laureys, G., Thomas, C., Luksch, R., Ladenstein, R., Haupt, R., Garaventa, A. & On behalf of SIOPEN Group, Jan 1 2018, In : Cancer Research and Treatment. 50, 1, p. 148-155 8 p.Research output: Contribution to journal › Article
Topotecan
Vincristine
Neuroblastoma
Doxorubicin
Pediatrics
Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study
SIOPEN Group, Jan 2018, In : Cancer Research and Treatment. 50, 1, p. 148-155 8 p.Research output: Contribution to journal › Article
Topotecan
Vincristine
Neuroblastoma
Doxorubicin
Pediatrics
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma
Morandi, F., Amoroso, L., Dondero, A., Castriconi, R., Parodi, S., Luksch, R., Casale, F., Castellano, A., Garaventa, A., Moretta, A., Bottino, C., Ponzoni, M. & Corrias, M. V., 2018, In : OncoImmunology. 7, 9Research output: Contribution to journal › Article